Definiendo el perfil del paciente candidato a 2 línea tras ITK

2 / 34

Disclosure Information
❑ Employment: None.
❑ Consultant or Advisory Role:Roche, Pfizer, Astellas, Sanofi, Ipsen, Jannsen.
❑ Stock Ownership:None.
❑ Research Funding: Astellas.
❑ Speaking: Astellas, Pfizer, Bayer, Novartis, Jannsen, BMS, MSD, Pierre-Fabre, Sanofi, Roche.
❑ Grant support: None